Showing results (11-20 of 3,811) with videos related to
Sort By:
Pageof 382
Experimental Hematology & Oncology|November 4, 2024
Nuclear porcupine mediates XRCC6/Ku70 S-palmitoylation in the DNA damage responseYang Chen, Mingming Xiao, Yaqi Mo, et al.Chemical Biology & Drug Design|February 12, 2016
Discovery of Novel Allosteric Eg5 Inhibitors Through Structure-Based Virtual ScreeningWei Zhang, Ling Zhai, Wenyan Lu, et al.American Journal of Physiology. Cell Physiology|February 4, 2011
BAX supports the mitochondrial network, promoting bioenergetics in nonapoptotic cellsRebecca J Boohaker, Ge Zhang, Adina Loosley Carlson, et al.Journal of Cancer|June 17, 2015
A MicroRNA Expression Signature In Taxane-anthracycline-Based Neoadjuvant Chemotherapy ResponseYi Zheng, Shuai Li, Rebecca J Boohaker, et al.Proceedings of the National Academy of Sciences of the United States of America|May 25, 2007
Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitmentChristopher L Haga, Götz R A Ehrhardt, Rebecca J Boohaker, et al.International Journal of Molecular Sciences|January 8, 2025
Structure Characterization of Zinc Finger Motif 1 and 2 of GLI1 DNA Binding RegionMousheng Wu, Nusrat Jahan, Amanda Sharp, et al.Molecular Pharmaceutics|May 18, 2012
Rational development of a cytotoxic peptide to trigger cell deathRebecca J Boohaker, Ge Zhang, Michael W Lee, et al.Frontiers in Oncology|October 3, 2022
Chaperonin containing TCP-1 (CCT/TRiC) is a novel therapeutic and diagnostic target for neuroblastomaAmanda Cox, Daniel Nierenberg, Oscar Camargo, et al.The Biochemical Journal|February 6, 2016
Discovery of a novel inhibitor of kinesin-like protein KIFC1Wei Zhang, Ling Zhai, Yimin Wang, et al.Clinical and Experimental Medicine|April 20, 2022
Novel targeted C3 inhibitor pegcetacoplan for paroxysmal nocturnal hemoglobinuriaBo XuPageof 382